Resilience funding news – Healthtech Company Resilience Secures $25 Million in Funding

In addition to creating a mobile app specifically for cancer patients, Remote has created a class IIa medical equipment that is a remote patient monitoring platform.

It became the first oncology-related remote monitoring medical equipment to be reimbursed by France's national social security in October 2023.

Red River West and Picus Capital are spearheading today's fundraiser. Additionally making new investments in resilience are Cathay Innovation, Singular, and Seaya Ventures.

Read also - Grey Wolf Therapeutics funding news – Clinical-stage Biotechnology Company Grey Wolf Therapeutics Secures $50 Million in Series B Round Funding

The company intends to increase the number of medical centres in Belgium where their technology is currently in use. It further filed a reimbursement application with the Belgian regulatory body (INAMI) in January 2024. Additionally, it aims to advance in Germany, where 500,000 new cases of cancer are diagnosed annually.

Céline Lazorthes and Jonathan Benhamou, co-founders and Co-CEOs of Resilience said, "Since we founded Resilience, we have always upheld a holistic vision deeply focused on patients and a strong mission to ensure better care. This financing will allow us to extend the positive impacts of remote monitoring, therapeutic education, and supportive care to a greater number of patients in France and abroad.”

The money will hasten the rollout of it's solution both domestically and internationally.

About Resilience

The goal of Resilience is to improve cancer treatment by providing oncology patients with remote monitoring and support. It offers a global solution to humanise, streamline, and personalise care pathways through synergistic technologies designed for patients and those providing care.